Lu Tian

Lu Tian

Stanford University

H-index: 76

North America-United States

About Lu Tian

Lu Tian, With an exceptional h-index of 76 and a recent h-index of 54 (since 2020), a distinguished researcher at Stanford University, specializes in the field of Biostatistics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Assessing Response for Nivolumab Plus Ipilimumab in Squamous Cell Carcinoma of the Head and Neck

A rank-based approach to evaluate a surrogate marker in a small sample setting

Using Restricted Mean Survival Time to Improve Interpretability of Time-to-Event Data Analysis

Predicting clinical progression trajectories of early Alzheimer's disease patients

Heterogeneous Treatment Effects of Intensive Glycemic Control on Kidney Microvascular Outcomes and Mortality in ACCORD

Evaluating a shrinkage estimator for the treatment effect in clinical trials

Plasma pTau181 reveals a pathological signature that predicts cognitive outcomes in Lewy body disease

Association of differential censoring with survival and suboptimal control arms among oncology clinical trials

Lu Tian Information

University

Position

___

Citations(all)

21674

Citations(since 2020)

11899

Cited By

15151

hIndex(all)

76

hIndex(since 2020)

54

i10Index(all)

267

i10Index(since 2020)

232

Email

University Profile Page

Stanford University

Google Scholar

View Google Scholar Profile

Lu Tian Skills & Research Interests

Biostatistics

Top articles of Lu Tian

Title

Journal

Author(s)

Publication Date

Assessing Response for Nivolumab Plus Ipilimumab in Squamous Cell Carcinoma of the Head and Neck

JAMA oncology

Layla Parast

Lu Tian

Lee-Jen Wei

2024/1/1

A rank-based approach to evaluate a surrogate marker in a small sample setting

Biometrics

Layla Parast

Tianxi Cai

Lu Tian

2024/3

Using Restricted Mean Survival Time to Improve Interpretability of Time-to-Event Data Analysis

Clinical Journal of the American Society of Nephrology

Vivek Charu

Lu Tian

Manjula Kurella Tamura

Maria E Montez-Rath

2024/2/1

Predicting clinical progression trajectories of early Alzheimer's disease patients

Alzheimer's & Dementia

Viswanath Devanarayan

Yuanqing Ye

Arnaud Charil

Erica Andreozzi

Pallavi Sachdev

...

2024/3

Heterogeneous Treatment Effects of Intensive Glycemic Control on Kidney Microvascular Outcomes and Mortality in ACCORD

Journal of the American Society of Nephrology

Vivek Charu

Jane W Liang

Glenn M Chertow

June Li

Maria E Montez-Rath

...

2024/1/11

Evaluating a shrinkage estimator for the treatment effect in clinical trials

Statistics in Medicine

Erik W van Zwet

Lu Tian

Robert Tibshirani

2024/2/28

Plasma pTau181 reveals a pathological signature that predicts cognitive outcomes in Lewy body disease

medRxiv

Carla Abdelnour

Christina B Young

Marian Shahid-Besanti

Alena Smith

Edward N Wilson

...

2024

Association of differential censoring with survival and suboptimal control arms among oncology clinical trials

JNCI: Journal of the National Cancer Institute

Eric J Hsu

Timothy A Lin

Dor R Dabush

Zachary McCaw

Alex Koong

...

2024/2/9

Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson’s disease

Acta Neuropathologica

Jarod Rutledge

Benoit Lehallier

Pardis Zarifkar

Patricia Moran Losada

Marian Shahid-Besanti

...

2024/6

Global metabolomics revealed deviations from the metabolic aging clock in colorectal cancer patients

Theranostics

Long Zhang

Shaobo Mo

Xiurui Zhu

C James Chou

Bo Jin

...

2024

Statistical Methods to Evaluate Surrogate Markers

Medical Care

Layla Parast

Lu Tian

Tianxi Cai

Latha Palaniappan

2024/2/1

Empowered Relief, cognitive behavioral therapy, and health education for people with chronic pain: a comparison of outcomes at 6-month Follow-up for a randomized controlled trial

Pain Reports

Beth D Darnall

John W Burns

Juliette Hong

Anuradha Roy

Kristin Slater

...

2024/1/1

Discordance of patient-reported outcome measures with objectively assessed walking decline in peripheral artery disease

Journal of Vascular Surgery

Mary M McDermott

Lu Tian

Dongxue Zhang

Lihui Zhao

Philip Greenland

...

2024/4/1

Precision medicine analysis of heterogeneity in individual‐level treatment response to amyloid beta removal in early Alzheimer's disease

Alzheimer's & Dementia

Menglan Pang

Audrey Gabelle

Paramita Saha‐Chaudhuri

Willem Huijbers

Arie Gafson

...

2023/10/26

Cigarette smoking and mitochondrial dysfunction in peripheral artery disease

Vascular Medicine

Michelle Guo

Mary M McDermott

Sudarshan Dayanidhi

Christiaan Leeuwenburgh

Stephanie Wohlgemuth

...

2023/2

Illusory responses across the Lewy body disease spectrum

Annals of Neurology

Marian Shahid

Ashley Rawls

Veronica Ramirez

Sephira Ryman

Veronica E Santini

...

2023/4

Testing for heterogeneity in the utility of a surrogate marker

Biometrics

Layla Parast

Tianxi Cai

Lu Tian

2023/6

Hierarchical Pretraining for Biomedical Term Embeddings

arXiv preprint arXiv:2307.00266

Bryan Cai

Sihang Zeng

Yucong Lin

Zheng Yuan

Doudou Zhou

...

2023/7/1

Exact inference for disease prevalence based on a test with unknown specificity and sensitivity

Journal of Applied Statistics

Bryan Cai

John PA Ioannidis

Eran Bendavid

Lu Tian

2023/9/10

Clinical Characteristics Associated With Response to Exercise and Serious Adverse Events During Home-Based Walking Exercise in People With Lower Extremity Peripheral Artery Disease

Circulation

Neela D Thangada

Dongxue Zhang

Lu Tian

Lihui Zhao

Mary M McDermott

2023/11/7

See List of Professors in Lu Tian University(Stanford University)

Co-Authors

H-index: 140
Cornelia Weyand

Cornelia Weyand

Stanford University

H-index: 121
Peter J Park

Peter J Park

Harvard University

H-index: 96
Brian Claggett

Brian Claggett

Harvard University

H-index: 94
Mary M. McDermott

Mary M. McDermott

North Western University

H-index: 49
Hajime Uno

Hajime Uno

Harvard University

academic-engine